The manuscript is titled 'Volanesorsen and Triglyceride Levels in Familial
Chylomicronemia Syndrome.'
Diagnostic algorithm for familial
chylomicronemia syndrome. Atheroscler Suppl.
This was also the first time I heard the term familial
chylomicronemia syndrome (FCS), which is a term used to describe LPLD and the other mutations that can cause this syndrome.
Familial lipoprotein lipase deficiency and other causes of the
chylomicronemia syndrome. In: Scriver C, Baudet A, Sly W, Valle D, eds.
The product is intended for the treatment of patients with Familial
Chylomicronemia Syndrome. FCS is a rare genetic disease characterized by extremely high triglyceride levels and risk of pancreatitis.
Akcea Therapeutics announced the publication of results from the first-ever study demonstrating the benefits of patient-to-patient connectivity in the management of familial
chylomicronemia syndrome. FCS is a rare, potentially life-threatening disease with multiple severe, daily and chronic manifestations that affect one's ability to work and engage in activities of everyday living.
M2 EQUITYBITES-July 7, 2015-Akcea Therapeutics wins US FDA's orphan drug designation for Volanesorsen for treating Familial
Chylomicronemia SyndromeAkcea Therapeutics (AKCA), up 11% after an FDA advisory committee voted 12-8 to support approval of volanesorsen for the treatment of people with familial
chylomicronemia syndrome. DOWN AFTER EARNINGS: Nvidia (NVDA), down 2.5%...
The most advanced drug in its pipeline, volanesorsen, has successfully completed a Phase 3 clinical program for the treatment of familial
chylomicronemia syndrome, or FCS, and is currently in Phase 3 clinical development for the treatment of familial partial lipodystrophy, or FPL.
Drug company Isis Pharmaceuticals (NasdaqGS:ISIS) announced on Thursday that it has initiated a Phase 3 study evaluating ISIS-APOCIIIRx in patients with familial
chylomicronemia syndrome (FCS), a rare orphan disease that is characterised by extremely high triglyceride levels.